273 related articles for article (PubMed ID: 16797254)
1. Chromosomal translocations involving the MLL gene: molecular mechanisms.
Aplan PD
DNA Repair (Amst); 2006 Sep; 5(9-10):1265-72. PubMed ID: 16797254
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II and the etiology of chromosomal translocations.
Felix CA; Kolaris CP; Osheroff N
DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
[TBL] [Abstract][Full Text] [Related]
3. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
[TBL] [Abstract][Full Text] [Related]
4. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach.
Binato R; Meyer C; Macedo-Silva ML; Garcia D; Figueiredo A; Hofmann J; Vieira TP; Abdelhay E; Marschalek R
Cancer Lett; 2013 Sep; 338(2):249-54. PubMed ID: 23562474
[TBL] [Abstract][Full Text] [Related]
5. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
Sung PA; Libura J; Richardson C
DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
[TBL] [Abstract][Full Text] [Related]
6. Potential role for wild-type p53 in leukemias with MLL gene translocations.
Megonigal MD; Rappaport EF; Nowell PC; Lange BJ; Felix CA
Oncogene; 1998 Mar; 16(10):1351-6. PubMed ID: 9546437
[TBL] [Abstract][Full Text] [Related]
7. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
[TBL] [Abstract][Full Text] [Related]
8. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
Mosad E; Abdou M; Zaky AH
Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
[TBL] [Abstract][Full Text] [Related]
9. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
[TBL] [Abstract][Full Text] [Related]
10. Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3).
Tuborgh A; Meyer C; Marschalek R; Preiss B; Hasle H; Kjeldsen E
Cytogenet Genome Res; 2013; 141(1):7-15. PubMed ID: 23735562
[TBL] [Abstract][Full Text] [Related]
11. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.
De Braekeleer M; Morel F; Le Bris MJ; Herry A; Douet-Guilbert N
Anticancer Res; 2005; 25(3B):1931-44. PubMed ID: 16158928
[TBL] [Abstract][Full Text] [Related]
12. A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia.
Ussowicz M; Jaśkowiec A; Meyer C; Marschalek R; Chybicka A; Szczepański T; Haus O
Cancer Genet; 2012 May; 205(5):261-5. PubMed ID: 22682626
[TBL] [Abstract][Full Text] [Related]
13. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
[TBL] [Abstract][Full Text] [Related]
14. KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.
Coenen EA; Zwaan CM; Meyer C; Marschalek R; Pieters R; van der Veken LT; Beverloo HB; van den Heuvel-Eibrink MM
Leuk Res; 2011 Jan; 35(1):133-5. PubMed ID: 20943269
[TBL] [Abstract][Full Text] [Related]
15. Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Janssen J; Maas LM; Godschalk RW; Nijhuis JG; van Schooten FJ
Carcinogenesis; 2007 Aug; 28(8):1703-9. PubMed ID: 17468513
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of MLL-associated leukemias.
Eguchi M; Eguchi-Ishimae M; Greaves M
Int J Hematol; 2005 Jul; 82(1):9-20. PubMed ID: 16105754
[TBL] [Abstract][Full Text] [Related]
18. A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia.
Sárová I; Brezinová J; Zemanová Z; Lizcová L; Berková A; Izáková S; Malinová E; Fuchs O; Kostecka A; Provazníková D; Filkuková J; Maaloufová J; Starý J; Michalová K
Cancer Genet Cytogenet; 2009 Dec; 195(2):150-6. PubMed ID: 19963115
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
20. RAS mutations in pediatric leukemias with MLL gene rearrangements.
Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
